6 Fibromyalgia Clinical Trials in Sacramento, CA (2026)

Q: How do I join a clinical trial in Sacramento?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you.

Recruiting Fibromyalgia Studies in Sacramento

NCT06238622Recruiting

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

This study is open to people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). They can only take part if they have completed treatment in a previous study with a medic...

Sacramento, CA1,700 participantsBoehringer Ingelheim

View Study Details

NCT05548283Recruiting

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or I...

Sacramento, CA730 participantsChris Goss

View Study Details

NCT05943535Recruiting

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period....

Sacramento, CA698 participantsUnited Therapeutics

View Study Details

NCT07652658Recruiting

A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

This Phase IIb study aims to evaluate the efficacy, safety, and tolerability of 3 doses of AZD8965 treatment compared to placebo in participants with IPF, including those on antifibrotic therapy (nint...

Sacramento, CA359 participantsAstraZeneca

View Study Details

NCT06559150Recruiting

A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis

This study is a randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of ensifentrine inhalation suspension (3 mg) delivered twice daily via standard jet nebuli...

Sacramento, CA284 participantsVerona Pharma plc

View Study Details

NCT05423691Recruiting

Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs

To assess the safety and tolerability of CK0804 as add-on therapy in participants with myelofibrosis, with suboptimal response to ruxolitinib...

Sacramento, CA24 participantsCellenkos, Inc.

View Study Details

About Fibromyalgia Clinical Trials in Sacramento

Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.

There are currently 6 fibromyalgia clinical trials recruiting participants in Sacramento, CA. These studies are seeking a combined 3,795 participants. Research is being sponsored by Boehringer Ingelheim, Chris Goss, United Therapeutics and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Fibromyalgia Clinical Trials in Sacramento — FAQ

Are there fibromyalgia clinical trials in Sacramento?

Yes, there are 6 fibromyalgia clinical trials currently recruiting in Sacramento, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Sacramento?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Sacramento research site will contact you about next steps.

Are clinical trials in Sacramento free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Sacramento studies also compensate for your time and travel.

What fibromyalgia treatments are being tested?

The 6 active trials in Sacramento are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.

Data updated July 13, 2026 from ClinicalTrials.gov